In a study, serum samples of admitted patients with a TIA/stroke diagnosis were collected to measure autoantibodies to NR2A/2B in the following intervals after initial symptoms: 3, 6, 9, 12, 24, and 72 h. This evidence concerns the gene GRIN2A and Stroke.